Sensus Healthcare (SRTS) EBIT (2016 - 2025)

Sensus Healthcare's EBIT history runs 10 years deep, the most recent figure standing at -$3.1 million for Q4 2025.

• On a quarterly basis, EBIT fell 282.39% year-over-year to -$3.1 million in Q4 2025; TTM through Dec 2025 was -$10.3 million, a 227.39% decrease from a year earlier, with the FY2025 full-year figure at -$10.3 million, down 227.4% from the prior year.
• EBIT retreated to -$3.1 million in Q4 2025 per SRTS's latest filing, from -$2.6 million in the prior quarter.
• Across five years, EBIT topped out at $5.6 million in Q4 2023 and bottomed at -$3.1 million in Q4 2025.
• The 5-year median for EBIT is $845000.0 (2021), against an average of $817650.0.
• Across the five-year window, EBIT soared 1969.65% in 2021 and slumped 282.39% in 2025, its largest moves.
• Year by year, EBIT stood at $5.3 million in 2021, then dropped by 21.56% to $4.2 million in 2022, then jumped by 33.68% to $5.6 million in 2023, then plunged by 69.05% to $1.7 million in 2024, then slumped by 282.39% to -$3.1 million in 2025.
• Per Business Quant, the three latest SRTS EBIT figures stand at -$3.1 million (Q4 2025), -$2.6 million (Q3 2025), and -$1.9 million (Q2 2025).